编号 | 时间 | 题目 | 讲者 | 单位 |
---|---|---|---|---|
1 | 08:30-08:50 |
不同人群的高血压管理 |
卢新政 | 江苏省人民医院(南京医科大学第一附属医院) |
Hypertension management in different populations |
Xinzheng Lu | The First Affiliated Hospital of Nanjing Medical University | ||
2 | 08:50-09:10 |
降压依从性管理与血压控制 |
卜培莉 | 山东大学齐鲁医院 |
Hypertensive compliance management and blood pressure control |
Peili Bu | Qilu Hospital of Shandong University | ||
3 | 09:10-09:30 |
药物基因组学指导降压药物选择的研究进展 |
于汇民 | 广东省人民医院 |
Research progress of pharmacogenomics guiding antihypertensive drugs selection |
Huimin Yu | Guangdong Provincial People's Hospital | ||
4 | 09:30-09:50 |
心衰治疗的新格局 |
余静 | 兰州大学第二医院 |
A new paradigm in heart failure treatment |
Jing Yu | Lanzhou University Second Hospital | ||
5 | 09:50-10:10 |
被忽略的心血管事件链:从HDP到CVD |
杨宁 | 泰达国际心血管病医院 |
Neglected chain of cardiovascular events: from HDP to CVD |
Ning Yang | Teda International Cardiovascular Hospital | ||
6 | 10:10-10:30 |
高血压合并脑卒中患者的血压管理 |
刘敏 | 河南省人民医院 |
Blood pressure management in patients with hypertension complicated with stroke |
Min Liu | Henan Provincial People's Hospital |
编号 | 时间 | 题目 | 讲者 | 单位 |
---|---|---|---|---|
1 | 10:30-11:00 |
尼可地尔在冠脉微血管功能障碍中的应用 |
宾建平 | 南方医科大学南方医院 |
Application of Nicodil in coronary microvascular dysfunction |
Jianping Bin | Nanfang Hospital of Southern Medical University | ||
2 | 11:00-11:30 |
小剂量起始联合降压方案,助力国人血压达标 |
廖新学 | 中山大学附属第一医院 |
Small dose starting combined antihypertensive program to help Chinese blood pressure reach the standard |
Xinxue Liao | Sun Yat-sen University First Affiliated Hospital | ||
3 | 11:30-12:00 |
糖尿病合并高血压患者血压控制和单片复方制剂降压治疗获益 |
冯颖青 | 广东省人民医院 |
Patients with diabetes and hypertension benefit from blood pressure control and single compound antihypertensive therapy |
Yingqing Feng | Guangdong Provincial People's Hospital |
编号 | 时间 | 题目 | 讲者 | 单位 |
---|---|---|---|---|
1 | 14:00-14:20 |
SGLT2i在非糖尿病合并CKD患者中的治疗机遇? |
黄恺 | 武汉大学人民医院 |
The Therapeutic Opportunity of SGLT2i in non-diabetic patients with CKD? |
Kai Huang | Renmin Hospital of Wuhan University | ||
2 | 14:20-14:25 |
讨论 |
||
Discussion |
||||
3 | 14:25-14:45 |
糖心共理 指南引航 |
李勇 | 复旦大学附属华山医院 |
The blood glucose and heart co-administration: clinical selection of GLP1 receptor agonists |
Yong Li | Huashan Hospital Fudan University | ||
4 | 14:45-14:50 |
讨论 |
||
Discussion |
||||
5 | 14:50-15:10 |
当生活方式还不够:降低胆固醇的药物方案选择? |
徐标 | 南京大学医学院附属鼓楼医院 |
When Lifestyle isn’t Enough: Pharmacological Approaches for Cholesterol Lowing |
Biao Xu | Nanjing Drum Tower Hospital | ||
6 | 15:10-15:15 |
讨论 |
||
Discussion |
||||
7 | 15:15-15:35 |
罕见代谢性心肌病的现状及发展 |
何旭瑜 | 广东省人民医院 |
Present and development of rare metabolic cardiomyopathy |
Xuyu He | Guangdong Provincial People's Hospital | ||
8 | 15:35-15:40 |
讨论 |
||
Discussion |
||||
9 | 15:40-15:50 |
休息与观展 |
||
Break and Exhibitions |
编号 | 时间 | 题目 | 讲者 | 单位 |
---|---|---|---|---|
1 | 15:50-16:10 |
强调心血管疾病患者的代谢综合管理:机遇与挑战! |
祁雨 | 北京大学第三医院 |
Emphasis on Integrated Metabolic Management in patients with cardiovascular disease: Opportunities and Challenges! |
yu qi | |||
2 | 16:10-16:15 |
讨论 |
||
Discussion |
||||
3 | 16:15-16:35 |
2023 ACC大会亮点荟萃-聚焦血脂前沿 |
郭远林 | 中国医学科学院阜外医院 |
Highlights from the 2023 ACC Conference--Focus on the forefront of blood lipids. |
Yuanlin Guo | Fuwai Hospital, Chinese Academy of Medical Sciences | ||
4 | 16:35-16:40 |
讨论 |
||
Discussion |
||||
5 | 16:40-17:00 |
调节血脂的小干扰RNA药物:从机制到临床 |
陈桢玥 | 上海交通大学医学院附属瑞金医院 |
Small interfering RNA drugs that regulate blood lipids: From Mechanisms to the clinic |
Zhenyue Chen | Ruijin Hospital, Shanghai Jiaotong University School of Medicine | ||
6 | 17:00-17:05 |
讨论 |
||
Discussion |
||||
7 | 17:05-17:25 |
Omega-3脂肪酸治疗降低ASCVD终点事件的前提条件是什么?-EPA水平是心血管获益的关键 |
黎励文 | 广东省人民医院 |
What are the prerequisites for Omega-3 fatty acid therapy to reduce ASCVD endpoint events- EPA levels are crucial for cardiovascular benefits |
Liwen Li | Guangdong Provincial People's Hospital | ||
8 | 17:25-17:30 |
讨论 |
||
Discussion |
||||
9 | 17:30-17:40 |
小结 |
||
|